Gitzer Oral Suspension contains Bacillus Clausii spores (2 billion per dose), a probiotic formulation intended to restore and maintain the natural balance of intestinal microflora. Bacillus Clausii is a non-pathogenic, spore-forming bacterium that exhibits resistance to gastric acidity and bile salts, allowing it to reach the intestines viable and exert its beneficial effects. This suspension is indicated for the prevention and treatment of gastrointestinal disturbances such as antibiotic-associated diarrhea, acute diarrhea, and dysbiosis resulting from infections or pharmacological therapies. By modulating the gut microbiota, Gitzer Oral Suspension helps inhibit the growth of pathogenic bacteria, supports the immune response, and promotes intestinal mucosal healing. It is suitable for use in both pediatric and adult populations. The recommended dosage should be followed as per medical advice, and the suspension should be shaken well before administration. Gitzer Oral Suspension is generally well tolerated, with minimal adverse effects reported. However, it is contraindicated in individuals with hypersensitivity to any component of the formulation or in cases of immunocompromised patients where probiotic use may pose risks. As with all medicinal products, it is advised to consult a healthcare professional prior to use to ensure safety and efficacy.